Current trends in quantitative structure-activity relationship validation and applications on drug discovery (2017)
- Authors:
- USP affiliated authors: HONORIO, KÁTHIA MARIA - EACH ; WRENGER, CARSTEN - ICB
- Unidades: EACH; ICB
- DOI: 10.4155/fsoa-2017-0052
- Subjects: RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA; PLANEJAMENTO DE FÁRMACOS; FÁRMACOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Science OA
- ISSN: 2056-5623
- Volume/Número/Paginação/Ano: v. 3, n. 4, p. FSO214-FSO216, jul. 2017
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
MALTAROLLO, Vinicius G. et al. Current trends in quantitative structure-activity relationship validation and applications on drug discovery. Future Science OA, v. 3, n. 4, p. FSO214-FSO216, 2017Tradução . . Disponível em: https://doi.org/10.4155/fsoa-2017-0052. Acesso em: 02 abr. 2026. -
APA
Maltarollo, V. G., Kronenberger, T., Wrenger, C., & Honorio, K. M. (2017). Current trends in quantitative structure-activity relationship validation and applications on drug discovery. Future Science OA, 3( 4), FSO214-FSO216. doi:10.4155/fsoa-2017-0052 -
NLM
Maltarollo VG, Kronenberger T, Wrenger C, Honorio KM. Current trends in quantitative structure-activity relationship validation and applications on drug discovery [Internet]. Future Science OA. 2017 ; 3( 4): FSO214-FSO216.[citado 2026 abr. 02 ] Available from: https://doi.org/10.4155/fsoa-2017-0052 -
Vancouver
Maltarollo VG, Kronenberger T, Wrenger C, Honorio KM. Current trends in quantitative structure-activity relationship validation and applications on drug discovery [Internet]. Future Science OA. 2017 ; 3( 4): FSO214-FSO216.[citado 2026 abr. 02 ] Available from: https://doi.org/10.4155/fsoa-2017-0052 - On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity
- Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses
- Advances and challenges in drug design of PPARδ ligands
- Oxidative stress in human infectious diseases - present and current - knowledge about its druggability
- Purification, crystallization and preliminary X-ray diffraction analysis of pyridoxal kinase from Plasmodium falciparum (PfPdxK)
- Exploring inhibition of Pdx1, a component of the PLP synthase complex of the human malaria parasite Plasmodium falciparum
- Trafficked Proteins—Druggable in Plasmodium falciparum?
- In vitro activity of extracts and isolated polyphenols from West African medicinal plants against Plasmodium falciparum
- Oxidative stress control by apicomplexan parasites
- Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
